UA84277C2 - Sustained-release tramadol formulations with 24-hour efficacy - Google Patents
Sustained-release tramadol formulations with 24-hour efficacyInfo
- Publication number
- UA84277C2 UA84277C2 UAA200504852A UA2005004852A UA84277C2 UA 84277 C2 UA84277 C2 UA 84277C2 UA A200504852 A UAA200504852 A UA A200504852A UA 2005004852 A UA2005004852 A UA 2005004852A UA 84277 C2 UA84277 C2 UA 84277C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sustained
- release tramadol
- tramadol formulations
- hour efficacy
- efficacy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28102602A | 2002-10-25 | 2002-10-25 | |
US51037803P | 2003-10-10 | 2003-10-10 | |
PCT/CA2003/001638 WO2004037222A2 (en) | 2002-10-25 | 2003-10-27 | Sustained-release tramadol formulations with 24-hour efficacy |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84277C2 true UA84277C2 (en) | 2008-10-10 |
Family
ID=32179487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200504852A UA84277C2 (en) | 2002-10-25 | 2003-10-27 | Sustained-release tramadol formulations with 24-hour efficacy |
Country Status (11)
Country | Link |
---|---|
JP (1) | JP2006507277A (en) |
KR (1) | KR20050083816A (en) |
AR (1) | AR045972A1 (en) |
AU (1) | AU2003275855B2 (en) |
CA (1) | CA2503155A1 (en) |
IL (1) | IL168114A (en) |
NO (1) | NO20052479D0 (en) |
PT (1) | PT1594460E (en) |
RU (1) | RU2328275C2 (en) |
UA (1) | UA84277C2 (en) |
WO (1) | WO2004037222A2 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
EP1905435A3 (en) * | 2003-03-11 | 2008-05-14 | Euro-Celtique S.A. | Titration dosing regimen for controlled release tramadol |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
NZ551288A (en) * | 2004-05-14 | 2010-10-29 | Janssen Pharmaceutica Nv | Carboxamido opioid compounds that are derivatives of tramadol |
DE102004032049A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Anti-abuse, oral dosage form |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
RU2008113439A (en) | 2005-09-09 | 2009-10-20 | Лабофарм Инк. (CA) | COMPOSITIONS WITH SLOW DELIVERY OF A MEDICINAL PRODUCT |
CA2648495C (en) * | 2006-04-26 | 2016-07-05 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
NZ586792A (en) | 2008-01-25 | 2012-09-28 | Gruenenthal Chemie | Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces |
RU2508092C2 (en) | 2008-05-09 | 2014-02-27 | Грюненталь Гмбх | Method for preparing solid dosage form, particularly tablet for pharmaceutical application and method for preparing solid dosage form precursor, particularly tablet |
DK2293794T3 (en) | 2008-05-27 | 2013-08-19 | Univ Melbourne | Method for treating mammals with dysfunction of the eustachian tube |
MY161550A (en) * | 2008-10-27 | 2017-04-28 | Alza Corp | Extended release oral acetaminophen/tramadol dosage form |
WO2011009604A1 (en) | 2009-07-22 | 2011-01-27 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
CN102573805A (en) | 2009-07-22 | 2012-07-11 | 格吕伦塔尔有限公司 | Hot-melt extruded controlled release dosage form |
WO2011095314A2 (en) | 2010-02-03 | 2011-08-11 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of an extruder |
PL2611426T3 (en) | 2010-09-02 | 2014-09-30 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
RU2607499C2 (en) | 2010-09-02 | 2017-01-10 | Грюненталь Гмбх | Destruction-resistant dosage form containing anionic polymer |
BR112014002022A2 (en) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | tamper-resistant tablet providing immediate drug release |
PT2736497T (en) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
EP2819656A1 (en) | 2012-02-28 | 2015-01-07 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
MX362357B (en) | 2012-04-18 | 2019-01-14 | Gruenenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form. |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
EP3003283A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
WO2015004245A1 (en) | 2013-07-12 | 2015-01-15 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
CN105934241B (en) | 2013-11-26 | 2020-06-05 | 格吕伦塔尔有限公司 | Preparation of powdered pharmaceutical composition by cryogenic grinding |
EP3142646A1 (en) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
MX2017013637A (en) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction. |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
EP3452024A1 (en) * | 2016-05-05 | 2019-03-13 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ260408A (en) * | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
DE19530575A1 (en) * | 1995-08-19 | 1997-02-20 | Gruenenthal Gmbh | Rapidly disintegrating drug form of tramadol or a tramadol salt |
EP1009387B1 (en) * | 1997-07-02 | 2006-04-12 | Euro-Celtique S.A. | Stabilized sustained release tramadol formulations |
DE10015479A1 (en) * | 2000-03-29 | 2001-10-11 | Basf Ag | Solid oral dosage forms with delayed release of active ingredient and high mechanical stability |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
DE10108122A1 (en) * | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Medicines based on tramadol |
-
2003
- 2003-10-27 PT PT03809237T patent/PT1594460E/en unknown
- 2003-10-27 JP JP2004545655A patent/JP2006507277A/en active Pending
- 2003-10-27 AU AU2003275855A patent/AU2003275855B2/en not_active Expired
- 2003-10-27 KR KR1020057007089A patent/KR20050083816A/en not_active Application Discontinuation
- 2003-10-27 UA UAA200504852A patent/UA84277C2/en unknown
- 2003-10-27 AR ARP030103926A patent/AR045972A1/en unknown
- 2003-10-27 CA CA002503155A patent/CA2503155A1/en not_active Abandoned
- 2003-10-27 WO PCT/CA2003/001638 patent/WO2004037222A2/en active IP Right Grant
- 2003-10-27 RU RU2005115855/15A patent/RU2328275C2/en not_active IP Right Cessation
-
2005
- 2005-04-19 IL IL168114A patent/IL168114A/en active IP Right Grant
- 2005-05-23 NO NO20052479A patent/NO20052479D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20052479L (en) | 2005-05-23 |
AU2003275855B2 (en) | 2009-04-23 |
WO2004037222A3 (en) | 2005-09-22 |
NO20052479D0 (en) | 2005-05-23 |
CA2503155A1 (en) | 2004-05-06 |
RU2328275C2 (en) | 2008-07-10 |
KR20050083816A (en) | 2005-08-26 |
RU2005115855A (en) | 2006-01-20 |
WO2004037222A2 (en) | 2004-05-06 |
JP2006507277A (en) | 2006-03-02 |
PT1594460E (en) | 2008-06-27 |
AU2003275855A1 (en) | 2004-05-13 |
AR045972A1 (en) | 2005-11-23 |
IL168114A (en) | 2011-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA84277C2 (en) | Sustained-release tramadol formulations with 24-hour efficacy | |
HK1101355A1 (en) | Sustained-release tramadol formulations with 24-hour efficacy 24 | |
UA84266C2 (en) | Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyroolidon as excipient, processes for the preparation and use thereof | |
AU2003271024A1 (en) | Sustained release compound of acetamidophenol and tramadol | |
NO20080827L (en) | Solid dosage formulations of narcotic drugs that have improved buccal adsorption | |
HK1076605A1 (en) | Formulations | |
IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
EP2298416A3 (en) | Sustained-release tramadol formulations with 24-hour clinical efficacy | |
HK1084941A1 (en) | Compounds and their use | |
EP1708685A4 (en) | Effervescent oral opiate dosage forms and methods of administering opiates | |
MY138734A (en) | Casr antagonist | |
HUP0104647A2 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
AU2003239389A1 (en) | Opioid receptor antagonists | |
NO20050771L (en) | Bicifadinformulering | |
HRP20041092A2 (en) | New pharmaceutical compositions containing filbanserin polymorph a | |
IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
WO2003005967A3 (en) | Dual release levodopa ethyl ester and decarboxylase in controlled release core | |
GB2411116A (en) | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative | |
TW200626141A (en) | Crystalline form of a drug | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
BR0114395A (en) | Pharmaceutical composition for oral supply administration | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments |